GGrantIndex
← Leaderboards

Stephanie Kristin Seidlits

University Of Texas At Austin

$3,388,351
Attributed
$7,295,147
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY201225
$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,295,147 · 6

By mechanism

UH3$2,380,820 · 1
UG3$2,134,549 · 1
R01$1,884,769 · 1
R21$827,083 · 2
F32$67,926 · 1

Most similar at University Of Texas At Austin

Same institution · by research overlap

Others in their field

Top investigators on “Response

Research focus

ResponseCellsBrain3-DimensionalPropertyNew Therapeutic TargetInsightTissuesInnovationBiocompatible MaterialsTreatment ResponseMediatingExposure ToEngineeringDesignCuesCell Culture TechniquesScaffoldCoculture TechniquesExtracellularEnvironmentExtracellular MatrixExhibitsEffective Therapy

Grant awards (16)

Studying synaptic transmission under opioid exposure using hiPSC-derived midbrain model and hyperspectral fluorescence lifetime imaging$181,740
R21 · FY2025 · DA
Multi-organ-on-chip device for modeling opioid reinforcement and withdrawal, and the negative affective component of pain: a therapeutic screening tool.$793,584
UH3 · FY2024 · TR
Tissue-Engineered Models of Glioblastoma for Evaluating Treatment Response$337,562
R01 · FY2024 · CA · contact PI
Studying synaptic transmission under opioid exposure using hiPSC-derived midbrain model and hyperspectral fluorescence lifetime imaging$221,843
R21 · FY2024 · DA
Multi-organ-on-chip device for modeling opioid reinforcement and withdrawal, and the negative affective component of pain: a therapeutic screening tool.$793,584
UH3 · FY2023 · TR
Tissue-Engineered Models of Glioblastoma for Evaluating Treatment Response$347,894
R01 · FY2023 · CA · contact PI
Multi-organ-on-chip device for modeling opioid reinforcement and withdrawal, and the negative affective component of pain: a therapeutic screening tool.$793,652
UH3 · FY2022 · TR
Tissue-Engineered Models of Glioblastoma for Evaluating Treatment Response$519,881
R01 · FY2022 · CA · contact PI
Multi-organ-on-chip device for modeling opioid reinforcement and withdrawal, and the negative affective component of pain: a therapeutic screening tool.$531,057
UG3 · FY2021 · TR
Tissue-Engineered Models of Microvessel-Mediated Glioblastoma Invasion$339,463
R01 · FY2021 · CA · contact PI
Tissue-Engineered Models of Microvessel-Mediated Glioblastoma Invasion$339,969
R01 · FY2020 · CA · contact PI
Multi-organ-on-chip device for modeling opioid reinforcement and withdrawal and the negative affective component of pain: a therapeutic screening tool.$1,603,492
UG3 · FY2019 · TR
Engineered microenvironments as biomimetic culture platforms for studying the role of brain extracellular matrix in acquisition of resistance to EGFR inhibition across multiple biological scales$192,500
R21 · FY2016 · NS · contact PI
Engineered microenvironments as biomimetic culture platforms for studying the role of brain extracellular matrix in acquisition of resistance to EGFR inhibition across multiple biological scales$231,000
R21 · FY2015 · NS · contact PI
Directed Differentiation of Stem Cell Transplants into Myelinating Glia$15,736
F32 · FY2014 · NS · contact PI
Directed Differentiation of Stem Cell Transplants into Myelinating Glia$52,190
F32 · FY2012 · NS · contact PI